Spring Bank Pharmaceuticals, Inc.·4

Nov 14, 8:46 AM ET

Driscoll Martin J 4

4 · Spring Bank Pharmaceuticals, Inc. · Filed Nov 14, 2019

Insider Transaction Report

Form 4
Period: 2019-11-13
Driscoll Martin J
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2019-11-13$2.83/sh+5,000$14,15090,400 total

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION